Sequana Medical Forecast, price target & analysts
€0.95
0.00%
today
Brüssel,
Apr 02, 05:35 pm CET
Sequana Medical Target price 2025 - Analyst rating & recommendation
Powered by
Sequana Medical Classifications & Recommendation:
Buy
100%
Sequana Medical Price Target
| Target Price | €4.50 |
| Price | €0.95 |
| Potential |
373.68%
register free of charge
|
| Number of Estimates | 2 |
|
2 Analysts have issued a price target Sequana Medical 2026 .
The average Sequana Medical target price is €4.50.
This is
373.68%
register free of charge
€5.00
426.32%
register free of charge
€4.00
321.05%
register free of charge
|
|
| A rating was issued by 2 analysts: 2 Analysts recommend Sequana Medical to buy, 0 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Sequana Medical stock has an average upside potential 2026 of
373.68%
register free of charge
|
Sales and Margin forecast 2025, 2026 & 2027
Create a premium account to unlock analyst estimates.
Learn more
Powered by
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Million € | 0.11 | 0.65 |
| 84.51% | 490.91% | |
| EBITDA Margin | -16,445.45% | -2,984.62% |
| 301.38% | 81.85% |
2 Analysts have issued a sales forecast Sequana Medical 2025 . The average Sequana Medical sales estimate is
€650k
Unlock
490.91%
higher
Unlock
€700k
536.36%
Unlock
€600k
445.45%
Unlock
This results in the following potential growth metrics:
1 Analyst has issued an EBITDA forecast Sequana Medical 2025 . The average Sequana Medical EBITDA estimate is
€-19.4m
Unlock
9.42%
lower
Unlock
€-19.4m
9.42%
Unlock
€-19.4m
9.42%
Unlock
This results in the following potential growth metrics and future EBITDA Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 & 2027
Create a premium account to unlock analyst estimates.
Learn more
Powered by
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| EV/Sales | 132.46 |
Current Sequana Medical Upgrades & Downgrades
Create a Premium account to unlock Upgrades/Downgrades.
Learn more
| Analyst | Rating | Action | Date |
|---|---|---|---|
| KBC SECURITIES |
Locked
➜
Locked
|
Locked | Jan 06 2025 |
| H.C. WAINWRIGHT & CO., LLC |
Locked
➜
Locked
|
Locked | Dec 23 2024 |
| DEGROOF PETERCAM |
Locked
➜
Locked
|
Locked | Dec 22 2024 |
| Analyst Rating | Date |
|---|---|
|
Locked
KBC SECURITIES:
Locked
➜
Locked
|
Jan 06 2025 |
|
Locked
H.C. WAINWRIGHT & CO., LLC:
Locked
➜
Locked
|
Dec 23 2024 |
|
Locked
DEGROOF PETERCAM:
Locked
➜
Locked
|
Dec 22 2024 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
